Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP)Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, central nervous system malformation, hereditary disease, hereditary sensory and autonomic neuropathy, inherited neurodegenerative disorder, megalencephaly-capillary malformation-polymicrogyria syndrome, nervous system disorder, neurodegenerative disease, neurodevelopmental disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, psychiatric disorderRecruitingPhase 22026-02-24NCT05577754

2 results · Page 1 of 1

Swipe the table sideways for more columns.

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AP-HP Hôpital Necker-Enfants MaladesParisFrance1
AP-HP Hôpital Necker-Enfants Malades - CICParisFrance1
CHRU BrestBrestFrance12
CHRU NîmesNîmesFrance1
CHRU ToursToursFrance11
CHU AmiensAmiensFrance1
CHU d'AngersAngersFrance25
Chu de LilleLilleFrance17
Chu Dijon BourgogneDijonFrance69
CHU Dijon Bourgogne - CIC-PDijonFrance1
Chu EstaingClermont-FerrandFrance14
CHU RennesRennesFrance2
HCL - Groupement Hospitalier Est Hôpital Femme-Mère-EnfantBronFrance1